Greg Bailey, Co-founder and Executive Chairman at Juvenescence, joins Phil Newman, Editor-in-Chief at Longevity.Technology, for a chat at Investing in the Age of Longevity 2023.

Highlighting the importance of preventitive medicine in the healthcare sector, Greg gives his own estimate of how the longevity space is going to develop over the next five years.

He also touches on the industry’s focus on regulation, and gives advice on how private investors can participate in the longevity space.

Having explained the Juvenescence model in more detail, Greg also gives an outlook on the company’s product range in 2024.